Atrial Tachypacing in the Treatment of a Patient with Primary Orthostatic Hypotension
- 26 June 1980
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (26) , 1456-1457
- https://doi.org/10.1056/nejm198006263022606
Abstract
PRIMARY orthostatic hypotension is an inexorably progressive condition characterized by symptoms and signs of sympathetic-nervous-system degeneration.1 A striking clinical feature of this disorder is severe orthostatic hypotension, often without compensatory tachycardia. To date, therapy for this condition has been less than satisfactory.2 3 4 Case ReportRecently, we saw a 77-year-old man with an eight-year history of progressive, incapacitating primary orthostatic hypotension that had been unresponsive to traditional therapies (mineralocorticoids, sympathomimetic amines, elastic stockings, and an antigravity suit). Neurologic examination revealed no abnormality of the central nervous system. The heart rate remained fixed at 72 beats per minute despite marked orthostatic reduction . . .Keywords
This publication has 9 references indexed in Scilit:
- Atrial pacing from the coronary vein. Ten-year experience in 50 patients with implanted pervenous pacemakers.Circulation, 1978
- Orthostatic Hypotension and SyncopeNew England Journal of Medicine, 1977
- The Sympathetic-Nervous-System Defect in Primary Orthostatic HypotensionNew England Journal of Medicine, 1977
- TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION WITH A MONOAMINE OXIDASE INHIBITOR AND TYRAMINEThe Lancet, 1976
- L–DOPA AND THE SHY–DRAGER SYNDROME *The Medical Journal of Australia, 1974
- Brady-tachy syndromeProgress in Cardiovascular Diseases, 1974
- Idiopathic postural hypotension: physiologic observations and report of a new mode of therapyJournal of Clinical Investigation, 1970
- Hemodynamic consequences of atrial and ventricular pacing in subjects with normal heartsThe American Journal of Cardiology, 1966
- Successful Treatment of Orthostatic Hypotension with 9-Alpha-FluorohydrocortisoneNew England Journal of Medicine, 1959